Filing Details

Accession Number:
0001493152-18-001223
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-01-29 21:58:37
Reporting Period:
2018-01-25
Accepted Time:
2018-01-29 21:58:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1133416 Galectin Therapeutics Inc GALT Pharmaceutical Preparations (2834) 043562325
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1453356 10X Fund, L.p. 1230 Peachtree Street, N.e.,
Suite 2445
Atlanta GA 30309
No No Yes No
1457247 10X Capital Management, Llc 1099 Forest Lake Terrace
Niceville FL 32578
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-01-25 205,144 $5.45 3,160,284 No 4 S Indirect See Footnote 1
Common Stock Disposition 2018-01-26 39,300 $5.35 3,120,984 No 4 S Indirect See Footnote 1
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote 1
No 4 S Indirect See Footnote 1
Footnotes
  1. 10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.